Selective leukemic-cell killing by a novel functional class of thalidomide analogs
about
Thalidomide analogues as anticancer drugsSelective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signalingPromoter-bound p300 complexes facilitate post-mitotic transmission of transcriptional memoryPolyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cellsNF-kappaB inhibitors from Brucea javanica exhibiting intracellular effects on reactive oxygen speciesLipid droplet binding thalidomide analogs activate endoplasmic reticulum stress and suppress hepatocellular carcinoma in a chemically induced transgenic mouse model.Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.Preformulation study of NSC-726796Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathwayMolecular pathway-specific 99mTc-N-(3-bromo-2,4,6-trimethyacetanilide) iminodiacetic acid liver imaging to assess innate immune responses induced by cell transplantationCombinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridol.Multiple myeloma cells' capacity to decompose H2O2 determines lenalidomide sensitivity.Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action.
P2860
Q24670383-F1136A53-4DC8-4A93-BB30-59E25137AC14Q28475888-5CBB2863-3EBB-422E-9535-C464525A5A0FQ33779012-74B55214-4428-4C2B-992E-82D0A4137B56Q33986673-E2110CB5-942B-4C3E-BC9F-9EE118C9964EQ34455279-166442C6-FBCF-4FC7-A047-4F0030EB953CQ34463693-6156C225-9DA1-4602-A753-1F00A5337B65Q35171777-348D65D8-947A-43B7-AF4B-8EBEA1ED497BQ35999066-4F5F43F7-C826-4F64-AA33-70FAC2CCE767Q36412841-6C6504A1-19EB-4AEA-BDA8-FA836FB4B253Q37157928-1CE1202F-7408-4E13-81D8-35D62CD1F039Q37424813-33DA0B7F-9A81-486B-9ACC-FE92C40E9DF9Q38724074-C113E959-E3AD-49B6-8B89-27B6F6C4038DQ47100906-EE7AC0EF-FC28-4172-8C3A-8475B98528D1
P2860
Selective leukemic-cell killing by a novel functional class of thalidomide analogs
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Selective leukemic-cell killing by a novel functional class of thalidomide analogs
@ast
Selective leukemic-cell killing by a novel functional class of thalidomide analogs
@en
type
label
Selective leukemic-cell killing by a novel functional class of thalidomide analogs
@ast
Selective leukemic-cell killing by a novel functional class of thalidomide analogs
@en
prefLabel
Selective leukemic-cell killing by a novel functional class of thalidomide analogs
@ast
Selective leukemic-cell killing by a novel functional class of thalidomide analogs
@en
P2093
P2860
P1433
P1476
Selective leukemic-cell killing by a novel functional class of thalidomide analogs
@en
P2093
Cynthia M Haggerty
Damaris Ponciano-Jackson
Erin R Gardner
G V R Chandramouli
Idalia Montano
Kevin Gardner
Maria Tsokos
Sharon H Jackson
Wendy J Freebern
P2860
P304
P356
10.1182/BLOOD-2006-04-017046
P407
P577
2006-08-29T00:00:00Z